Cimzia (certolizumab) is a biologic medicine that helps the pain and swelling of arthritis. It works by blocking Tumor Necrosis Factor (TNF), a type of signalling protein (called a cytokine), that is involved in systemic inflammation.
Cimzia belongs to a class of similar medications called "Anti-Tumor Necrosis Factor" agents.
Cimzia is available in pre-filled syringes or an autoinjectors and is usually taken once every 2 weeks.
Although some patients can feel better quite quickly in others it can take a little longer. Patients starting Cimizia should continue taking the medication as prescribed.
The manufacturer of Cimzia offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Watch Dr. Andy Thompson, a Canadian rheumatologist, introduce Cimzia in a short video:
Drug Identification Number (DIN)
02331675 (Pre-filled Syringe)